Intuitive maintains 13.5%-15.5% 2026 da Vinci procedure growth outlook while outlining 68%-69% non-GAAP gross margin range (NASDAQ:ISRG)

Intuitive Surgical (ISRG) Q2 2026 earnings call highlights: procedure growth, U.S.

Intuitive maintains 13.5%-15.5% 2026 da Vinci procedure growth outlook while outlining 68%-69% non-GAAP gross margin range (NASDAQ:ISRG) | Seeking Alpha

Save

Play

(

10min

)

Comments

Earnings Call Insights: Intuitive Surgical (ISRG) Q2 2026

Management View

“Our performance in Q2 was solid,” said CEO David Rosa, reporting that “total procedures increased 16% driven by 15% growth in da Vinci procedures and 36% growth in Ion procedures,” and adding that the company “exited the quarter

Seeking Alpha's Disclaimer:

This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please

report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Search field

Entering text into the input field will update the search result below

Entering text into the input field will update the search result below

Quick Insights

How is U.S. da Vinci procedure growth affected by ACA coverage changes?

U.S. da Vinci procedure growth moderated, attributed partially to ACA-related coverage and premium dynamics affecting patient treatment timing.

What is the outlook for Intuitive Surgical's 2026 procedure growth and margins?

Management maintained 2026 da Vinci procedure growth of 13.5%-15.5% (closer to the midpoint) and raised non-GAAP gross margin guidance to 68%-69%.

What are the expected financial impacts of the 2027 extended-use program for Intuitive Surgical instruments?

Financial impacts are unquantified, as management said it's too early to detail savings; adoption is expected to have a progressive, not step change, effect starting in 2027.

Recommended For You

More

Trending News

See More

»